JEOL (6951) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
14 Aug, 2026Executive summary
Net sales for the quarter ended June 30, 2026, declined 39.1% year-over-year to ¥24,465 million, with a net loss attributable to owners of parent of ¥1,710 million compared to a profit of ¥4,669 million in the prior year.
Operating profit turned negative at ¥(1,961) million, down from ¥5,792 million a year earlier.
Comprehensive income was negative ¥204 million, a significant drop from ¥3,966 million in the previous year.
Financial highlights
Gross profit for the quarter was ¥11,768 million, down from ¥19,451 million year-over-year.
Basic earnings per share fell to ¥(35.12) from ¥91.32 year-over-year.
Equity-to-asset ratio improved to 62.3% as of June 30, 2026, from 59.9% at March 31, 2026.
Total assets decreased to ¥226,162 million from ¥242,026 million at the end of the previous fiscal year.
Outlook and guidance
Full-year net sales forecast for fiscal year ending March 31, 2027, is ¥164,000 million, down 8.6% year-over-year.
Operating profit is projected at ¥26,500 million, up 1.9% year-over-year, with profit attributable to owners of parent expected at ¥21,300 million, down 3.6%.
No revisions to previously announced earnings or dividend forecasts.
Latest events from JEOL
- Record net profit and share repurchase amid lower sales and business portfolio shift.6951
Q4 2026 - Revenue and profit fell, but financial stability and growth initiatives were maintained.6951
Q3 2026 - Vertical argon ion etching delivers uniform, high-resolution depth profiling with minimal roughness.6951
Status update - Sales and profits fell year-over-year, but Medical Equipment outperformed and dividends remain robust.6951
Q2 2026 - Strong quarterly growth in sales and profit, but full-year outlook signals a slight decline.6951
Q1 2026 - Strong sales growth and margin expansion drive upward revision to full-year outlook.6951
Q2 2025 - Revenue and profit surged in Q1 FY2025, led by robust equipment demand; outlook unchanged.6951
Q1 2025 - Record sales and profit, but lower net income and cautious outlook for next year.6951
Q4 2025 - Record profits and sales driven by robust equipment demand and margin gains.6951
Q3 2025